These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5682339)

  • 21. [Thyroid medullary cancer: does the hyperthyrocalcitonin syndrome exist?].
    Milhaud G; Coutris G; Tubiana M
    Probl Actuels Endocrinol Nutr; 1969; 13():111-33. PubMed ID: 5404018
    [No Abstract]   [Full Text] [Related]  

  • 22. Bone metastases of thyroid cancer biological behaviour and therapeutic possibilities.
    Nĕmec J; Zamrazil V; Pohunková D; Matĕjovský Z; Soumar J; Zeman V; Röhling S; Holík F; Bednár J
    Acta Univ Carol Med Monogr; 1978; (83):7-106. PubMed ID: 375703
    [No Abstract]   [Full Text] [Related]  

  • 23. Diagnostic approach, genetic screening and prognostic factors of medullary thyroid carcinoma.
    Corsello SM; Lovicu RM; Migneco MG; Rufini V; Summaria V
    Rays; 2000; 25(2):257-66. PubMed ID: 11370543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Radioimmunological determination of calcitonin in monitoring medullary carcinoma of the thyroid].
    Trucchi M; Marchisio M; Roncallo F; Schenone F; Santaniello B
    Arch Maragliano Patol Clin; 1980; 36():25-30. PubMed ID: 6896418
    [No Abstract]   [Full Text] [Related]  

  • 25. The diagnosis and therapy of medullary thyroid carcinoma in childhood.
    Bindewald H; Raue F; Merkle P
    Prog Pediatr Surg; 1983; 16():43-6. PubMed ID: 6878728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Medullary cancer of the thyroid].
    Paches AI; Propp RM; Abdullin NA; Anokhin BM
    Vopr Onkol; 1982; 28(5):77-82. PubMed ID: 7090286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combining provocative agents of calcitonin to detect medullary carcinoma of the thyroid.
    Sisson JC; Gross MD; Frietas JE; Jackson CE; England BG
    Henry Ford Hosp Med J; 1981; 29(2):75-80. PubMed ID: 7263287
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic approach to bone metastases from thyroid gland cancers].
    Garnier H; Massin JP; Bacourt F; Thomopoulos P
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1972 Sep; 21(7):591-6. PubMed ID: 4263732
    [No Abstract]   [Full Text] [Related]  

  • 29. [Value of the assay of plasma carcinoembryonic antigen and thyrocalcitonin in the detection of medullary cancer of the thyroid with amyloid stroma. Results of a familial survey of 47 subjects].
    Allanic H
    Ann Med Interne (Paris); 1984; 135(5):341-4. PubMed ID: 6486613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Skeletal scintiscanning with Sr85 in the search for osseous metastases of neoplasms of the female genital system].
    Doria-Miglietta F; Sanguineti M
    Cancro; 1967; 20(4):393-9. PubMed ID: 5622979
    [No Abstract]   [Full Text] [Related]  

  • 31. [Ectopic thyrocalcitonin secretion].
    Milhaud G; Calmettes C; Moukhtar MS
    Rev Med Suisse Romande; 1970 Jul; 90(7):539-46. PubMed ID: 5516319
    [No Abstract]   [Full Text] [Related]  

  • 32. [Metastasis of the cervico-occipital hinge joint].
    Bonneville JF; Tuetey JB; Jacquet G; Steimle R; Schraub S
    Nouv Presse Med; 1978 Sep; 7(32):2877. PubMed ID: 714680
    [No Abstract]   [Full Text] [Related]  

  • 33. [Proposal for the protocol of a national multidisciplinary study of medullary thyroid cancer].
    Trotoux J
    Ann Otolaryngol Chir Cervicofac; 1984; 101(4):331-4. PubMed ID: 6380375
    [No Abstract]   [Full Text] [Related]  

  • 34. [Autopsy case of simultaneous triple malignancies--ovarian, chordoma and thyroid cancers].
    Yamamoto Y; Moriwaki S; Takashima S; Yumoto Y
    Gan No Rinsho; 1983 Sep; 29(11):1375-8. PubMed ID: 6632220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Critical remarks on medullary cancer of the thyroid].
    Faret S; Pomata M; Scintu F; Ledda P
    Minerva Med; 1983 Dec; 74(47-48):2807-14. PubMed ID: 6657122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis of familial medullary cancers].
    Argémi B; Vagneur JP; Cannoni M; Charpin C; Even F; Rollat MC; Bollet C
    Biomed Pharmacother; 1984; 38(5):270-2. PubMed ID: 6525427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should treatment of highly differentiated thyroid carcinoma be conservative?
    Biersack HJ; Helpap B; Koch U; Janson R; Baumgarten C; Winkler C
    Nuklearmedizin; 1983 Feb; 22(1):20-3. PubMed ID: 6866776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Multiple condensing osseous metastases of a thyroid adenocarcinoma].
    Louyot P; Gaucher A; Manivit P; Masingue M; Macinot C
    Rev Rhum Mal Osteoartic; 1968 Jun; 35(6):348-52. PubMed ID: 5701051
    [No Abstract]   [Full Text] [Related]  

  • 40. [Value of immunohistochemistry in the study of medullary cancer of the thyroid. Implications of the results for the concept of the APUD system and of apudomas].
    Caillou B; Rougier P; Schlumberger M; Talbot M; Parmentier C
    Bull Cancer; 1984; 71(2):140-4. PubMed ID: 6145461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.